Pre-market · Oct 8, 8:20 am ET · After hours $8.88 0.00%
Open$8.65
Prev close$8.76
Day range$8.60 – $8.97
Volume631.6K
Market cap$629.67M
P/E (TTM)–
Dividend yield–
SGMT Stock News
Headlines matching Sagimet Biosciences or the SGMT ticker, most recent first.
Barclays Upgrades Sagimet Biosciences(SGMT.US) to Buy Rating, Raises Target Price to $18PositiveMarket news · 9 Sep 2026 · Direct mention
Cantor Fitzgerald Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $26Market news · 9 Sep 2026 · Direct mention
JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31Market news · 28 Sep 2026 · Direct mention
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)TipRanks · 28 Sep 2026 · Direct mention
Goldman Sachs Initiates Sagimet Biosciences(SGMT.US) With Sell Rating, Announces Target Price $7Market news · 24 Sep 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)TipRanks · 25 Aug 2026 · Direct mention
A Quick Look at Today's Ratings for Sagimet Biosciences(SGMT.US), With a Forecast Between $25 to $49Market news · 12 Aug 2026 · Direct mention
Oppenheimer Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $33Market news · 12 Aug 2026 · Direct mention
H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $29Market news · 5 Oct 2026 · Direct mention
Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT)PositiveTipRanks · 5 Oct 2026 · Direct mention
Leerink Partners Maintains Sagimet Biosciences(SGMT.US) With Buy RatingMarket news · 2 Oct 2026 · Direct mention
Guggenheim Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Raises Target Price to $26PositiveMarket news · 2 Oct 2026 · Direct mention
A Quick Look at Today's Ratings for Sagimet Biosciences(SGMT.US), With a Forecast Between $25.1 to $56Market news · 1 Oct 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)TipRanks · 1 Oct 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Liquidia Technologies (LQDA)TipRanks · 1 Oct 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on SGMT.
No comments yet — be the first to weigh in on SGMT.